BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17914651)

  • 21. Serum hepatocyte growth factor as a prognostic marker for stage II or III colorectal cancer patients.
    Toiyama Y; Miki C; Inoue Y; Okugawa Y; Tanaka K; Kusunoki M
    Int J Cancer; 2009 Oct; 125(7):1657-62. PubMed ID: 19569242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction.
    Jonas S; Windeatt S; O-Boateng A; Fordy C; Allen-Mersh TG
    Gut; 1996 Nov; 39(5):717-21. PubMed ID: 9014772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction.
    Castells A; Boix L; Bessa X; Gargallo L; Piqué JM
    Br J Cancer; 1998 Nov; 78(10):1368-72. PubMed ID: 9823981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of carcinoembryonic antigen (CEA) density as a prognostic factor for percutaneous ablation of pulmonary colorectal metastases.
    Huo YR; Glenn D; Liauw W; Power M; Zhao J; Morris DL
    Eur Radiol; 2017 Jan; 27(1):128-137. PubMed ID: 27165139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The serum level of carcinoembryonic antigen in drainage venous blood is not a sensitive predictor of metachronous hepatic metastasis for patients with colorectal cancer.
    Haraguchi M; Fujita F; Torashima Y; Inokuma T; Tajima Y; Kanematsu T
    Surg Today; 2010 Aug; 40(8):745-51. PubMed ID: 20676859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased detection of circulating tumor cells in the blood of colorectal carcinoma patients using two reverse transcription-PCR assays and multiple blood samples.
    Wharton RQ; Jonas SK; Glover C; Khan ZA; Klokouzas A; Quinn H; Henry M; Allen-Mersh TG
    Clin Cancer Res; 1999 Dec; 5(12):4158-63. PubMed ID: 10632355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer.
    Carpelan-Holmström M; Haglund C; Lundin J; Järvinen H; Roberts P
    Eur J Cancer; 1996 Jun; 32A(7):1156-61. PubMed ID: 8758246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of cytokeratin-20 and carcinoembryonic antigen mRNA detection by RT-PCR in regional lymph nodes of patients with colorectal cancer.
    Rosenberg R; Hoos A; Mueller J; Nekarda H
    Br J Cancer; 2000 Nov; 83(10):1323-9. PubMed ID: 11044357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients.
    Rosenberg R; Hoos A; Mueller J; Baier P; Stricker D; Werner M; Nekarda H; Siewert JR
    J Clin Oncol; 2002 Feb; 20(4):1049-55. PubMed ID: 11844829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative analysis of tumor markers and evaluation of their predictive value in patients with colorectal cancer.
    Liu ZP; Li LM; Liu XL; Zhang DX
    Onkologie; 2012; 35(3):108-13. PubMed ID: 22414974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of carcinoembryonic antigen levels in peripheral and draining venous blood in patients with colorectal carcinoma.
    Waisberg J; Contim-Neto L; Oliveira Mda S; Matheus Cde O; Nagashima CA; Goffi FS
    Arq Gastroenterol; 2004; 41(2):88-92. PubMed ID: 15543380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer.
    Cai D; Huang ZH; Yu HC; Wang XL; Bai LL; Tang GN; Peng SY; Li YJ; Huang MJ; Cao GW; Wang JP; Luo YX
    World J Gastroenterol; 2019 Sep; 25(33):4945-4958. PubMed ID: 31543685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the significance of expression of CEA mRNA and levels of CEA and its related proteins in colorectal cancer patients.
    Wang W; Li Y; Zhang X; Jing J; Zhao X; Wang Y; Han C
    J Surg Oncol; 2014 Apr; 109(5):440-4. PubMed ID: 24783267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.
    Herszényi L; Farinati F; Cardin R; István G; Molnár LD; Hritz I; De Paoli M; Plebani M; Tulassay Z
    BMC Cancer; 2008 Jul; 8():194. PubMed ID: 18616803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Importance of Determining Preoperative Serum Concentration of Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Assessing the Progression of Colorectal Cancer.
    Halilovic E; Rasic I; Sofic A; Mujic A; Rovcanin A; Hodzic E; Kulovic E
    Med Arch; 2020 Oct; 74(5):346-349. PubMed ID: 33424087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are high initial CEA and CA 19-9 levels associated with the presence of K-ras mutation in patients with metastatic colorectal cancer?
    Selcukbiricik F; Bilici A; Tural D; Erdamar S; Soyluk O; Buyukunal E; Demirelli F; Serdengecti S
    Tumour Biol; 2013 Aug; 34(4):2233-9. PubMed ID: 23625655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour cell dissemination following endoscopic stent insertion.
    Maruthachalam K; Lash GE; Shenton BK; Horgan AF
    Br J Surg; 2007 Sep; 94(9):1151-4. PubMed ID: 17541987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.